UZ Gasthuisberg Leuven Nierziekten
About UZ Gasthuisberg Leuven Nierziekten
Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.
There are 1,995 beds in UZ Gasthuisberg Leuven Nierziekten.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AZ-VUB
4
Henogen
4
Clinical Trials at UZ Gasthuisberg Leuven Nierziekten
During the past decade, UZ Gasthuisberg Leuven Nierziekten conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
2006-02-01
2007-03-01
Completed
300
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
2006-03-01
2007-10-01
Completed
257
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
2006-03-01
2007-10-01
Completed
185
Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts
Terminated
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
2007-03-01
2009-11-01
Completed
102
Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes
2000-09-01
2005-10-01
Completed
36
Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
2000-06-01
2007-03-01
Completed
80
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
2000-02-01
2007-11-01
Completed
112
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Gasthuisberg Leuven Nierziekten"
#1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Erasme University Hospital" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator, "Belgian Government" with 1 trials as a collaborator and "Fund for Scientific Research, Flanders, Belgium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at UZ Gasthuisberg Leuven Nierziekten
According to Clinical.Site data, the most researched conditions in "UZ Gasthuisberg Leuven Nierziekten" are
"Hepatitis B" (4 trials), "Diabetes Mellitus, Type 1" (2 trials), "Diabetes, Type I" (1 trials), "Islet Transplantation" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "UZ Gasthuisberg Leuven Nierziekten" in a lesser frequency.
Clinical Trials Intervention Types at UZ Gasthuisberg Leuven Nierziekten
Most popular intervention types in "UZ Gasthuisberg Leuven Nierziekten" are "Biological" (4 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "HBVAXPRO vaccine" (2 trials), "ATG-Sirolimus-Tacrolimus" (1 trials), "Actrapid HM" (1 trials), "ChAgly CD3" (1 trials) and "FENDRIX" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UZ Gasthuisberg Leuven Nierziekten
The vast majority of trials in "UZ Gasthuisberg Leuven Nierziekten" are
7 trials for "All" genders.
Clinical Trials Status at UZ Gasthuisberg Leuven Nierziekten
Currently, there are NaN active trials in "UZ Gasthuisberg Leuven Nierziekten".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in UZ Gasthuisberg Leuven Nierziekten,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UZ Gasthuisberg Leuven Nierziekten, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".